From nano to micro: using nanotechnology to combat microorganisms and their multidrug resistance
M Natan, E Banin - FEMS microbiology reviews, 2017 - academic.oup.com
The spread of antibiotic resistance and increasing prevalence of biofilm-associated
infections is driving demand for new means to treat bacterial infection. Nanotechnology …
infections is driving demand for new means to treat bacterial infection. Nanotechnology …
[HTML][HTML] Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches
Tuberculosis (caused by Mycobacterium tuberculosis, Mtb) treatment involves multiple drug
regimens for a prolonged period. However, the therapeutic benefit is often limited by poor …
regimens for a prolonged period. However, the therapeutic benefit is often limited by poor …
Nanotechnology‐based targeted drug delivery: an emerging tool to overcome tuberculosis
The appearance and rapid spread of drug resistant strains of tuberculosis (TB), one of the
deadliest infectious diseases, pose a serious threat to public health and increase the need …
deadliest infectious diseases, pose a serious threat to public health and increase the need …
Uptake and Intracellular Fate of Engineered Nanoparticles in Mammalian Cells: Capabilities and Limitations of Transmission Electron Microscopy—Polymer‐Based …
In order to elucidate mechanisms of nanoparticle (NP)–cell interactions, a detailed
knowledge about membrane–particle interactions, intracellular distributions, and nucleus …
knowledge about membrane–particle interactions, intracellular distributions, and nucleus …
Innovative therapeutic approaches based on nanotechnology for the treatment and management of tuberculosis
Tuberculosis (TB), derived from bacterium named Mycobacterium tuberculosis, has become
one of the worst infectious and contagious illnesses in the world after HIV/AIDS. Long-term …
one of the worst infectious and contagious illnesses in the world after HIV/AIDS. Long-term …
Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future
Tuberculosis (TB) is a contagious and airborne infectious disease caused by the pathogen
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …
Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of Mycobacterium tuberculosis through induction of autophagy and augment anti …
PK Gupta, P Jahagirdar, D Tripathi… - Frontiers in …, 2023 - frontiersin.org
Rapid emergence of antibiotic resistance in tuberculosis has left us with limited resources to
treat and manage multi drug resistant (MDR) cases of tuberculosis, prompting the …
treat and manage multi drug resistant (MDR) cases of tuberculosis, prompting the …
Nanocarriers in tuberculosis treatment: challenges and delivery strategies
The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium
tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist …
tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist …
Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis
L Shao, S Shen, H Liu - Frontiers in bioengineering and …, 2022 - frontiersin.org
Tuberculosis is a severe infectious disease caused by Mycobacterium tuberculosis and is a
significant public health concern globally. The World Health Organization (WHO) …
significant public health concern globally. The World Health Organization (WHO) …